Free Treatment For Cancer – Enroll For Clinical Trials - ACRI India

Nearly 10 lakh new cancer cases are detected in India every year! Can you imagine this huge number!? And, most of the cases are those of breast cancer in women. This is why medical science is always on the course of finding newer and better treatments and therapies for such patients. And for this, clinical trials are important. As clinical trials become important, the requirement of more and more patients also becomes important.

The Latest Tuberculosis Alert: Mutations In Bacteria Make It Resistant To Drugs!

For the past few days, we have been discussing about the new vaccine that has been founded by the Indian Council of Medical Research (ICMR) to fight tuberculosis in adults, decades after the most famous BCG vaccine has been founded. Because the BCG vaccine has been found successful only for newborns, the ICMR decided to come up with a new vaccine specially designed for adults. While on the one hand, India has begun the clinical trial of this new tuberculosis vaccine, on the other hand, our scientists have come up with yet another startling finding.

Why Should Physicians Attend Clinical Research Virtual Training Programs?

The clinical research industry has seen a huge momentum with the increasing size of the pharmaceutical industry and the demand for developing new drugs. And, no clinical research results can be achieved without the contribution of physicians trained in conducting research. More and more physicians want to pursue a career in clinical research, but with the number of challenges that they face, it is becoming even more difficult. To fight such challenges and bring about a comfort to pursue such careers, there are various strategies that have been developed; and one such approach is clinical researchvirtual training programs.

ICMR Makes Ethical Guidelines for Biomedical Research Mandatory - ACRI India

The Indian Council of Medical Research (ICMR) has issued certain National Ethical Guidelines for Biomedical Research, which has now become mandatory. Every biomedical research in the country needs to adhere to these guidelines, as per the New Drugs and Clinical Trials Rules 2019. These new rules had been recently released by the Ministry of Health and Family Welfare, Government of India.

How Has India Broken The Taboo Of Clinical Trials - ACRI India

India has over the years seen a sharp decline in clinical trials. This is inadequate for a country with the second highest population and the highest disease burden in the world. However, the rules have been changing since some time, which has been changing the scenario. With the new rules and regulations, confidence is being seen among stakeholders.

Clinical Trial Monitoring – What Is It?

Clinical trial monitoring checks on the safety, rights, and well-being of clinical trial subjects to ensure that they are protected. It also checks for the data coming out of a clinical trial to be accurate and credible. This kind of monitoring is carried out by a sponsor representatve, like the Clinical Research Associate (CRA) by visiting a clinical trial site in person at regular intervals, where the sponsors study is being conducted. Along with other duties andresponsibilities of a CRA , there is a lot that the CRA has to do to conduct a clinical trial monitoring.

Tisotumab Vedotin – The Cancer Killer

Cancer is one of the most prevalent diseases that patients suffer from across the globe. It could be blood cancer, breast cancer, mouth cancer, or any other kind of cancer. While there have been a lot many experiments that have been conducted over the years to help treat cancer patients, none of them have proven to kill the cancer cells completely from the body. But recently, a novel cancer drug known as “Tisotumab Vedotin” has been found which can destroy tumours from within the body. This drug has shown promising results across six different forms of cancer! These included advanced drug-resistant cancers, cervical cancers, lung cancers, bladder cancers, and ovarian cancers. This is possible because the drug releases a toxic substance to kill cancer cells from within. With the success of this drug, it has now been moved forward to the Phase-II trials, where it will be further tested in a range of additional cancer types like head, neck, bowel, pancreatic, and squamous cell lung cancers.